Eyal Flom

Director/Board Member en INNOCAN PHARMA CORPORATION .

Fortuna: 534 437 $ al 31/03/2024

59 años

16 relaciones

Health Technology

Consumer Services

Distribution Services

Perfil

Eyal Flom is currently the Director at Revium Recovery, Inc. He is also the Secretary & Director at InnoCan Pharma Corp.
and the Director at NurExone Biologic Ltd.
In the past, he served as the Legal Counsel at the Israeli Pharmaceutical Association.
Mr. Flom's former job includes being the Director at NurExone Biologic, Inc. Mr. Flom holds an MBA from the University of Derby and a graduate degree from Tel-Aviv University.

Participaciones conocidas en empresas públicas

Empresa	Fecha	Número de acciones	Valoración	Fecha de valoración
INNOCAN PHARMA CORPORATION 0.89%	25/03/2024	2 375 277 ( 0.89% )	534 437 $	31/03/2024

Cargos activos de Eyal Flom

Empresas	Cargo	Inicio
INNOCAN PHARMA CORPORATION	Director/Board Member	25/09/2019
REVIUM RECOVERY INC.	Director/Board Member	-
Israeli Pharmaceutical Association	General Counsel	01/04/1995
NurExone Biologic Ltd. NurExone Biologic Ltd. Pharmaceuticals: MajorHealth Technology Part of NurExone Biologic, Inc., NurExone Biologic Ltd. is an Israeli company that offers a new approach to Spinal Cord Injury treatment. The private company is based in Bnei-Brak, Israel. The company believes that intranasal exosome administration offers an alternative to cell transplantation. The company was founded in 2020 by Yoram Nathan Drucker. Lior Shaltiel has been the CEO of the company since 2021. NurExone Biologic was acquired by EnerSpar Corp. on June 15, 2022.	Director/Board Member	-

Todos los cargos activos de Eyal Flom

Antiguos cargos conocidos de Eyal Flom.

Empresas	Cargo	Fin
NUREXONE BIOLOGIC INC.	Director/Board Member	08/05/2023

Ver el detalle de la experiencia de Eyal Flom.

Formación de Eyal Flom.

University of Derby	Masters Business Admin
Tel-Aviv University	Graduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Eyal Flom.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	3
REVIUM RECOVERY INC.	Distribution Services
INNOCAN PHARMA CORPORATION	Health Technology
NUREXONE BIOLOGIC INC.	Health Technology

Empresas privadas	2
Israeli Pharmaceutical Association
NurExone Biologic Ltd. NurExone Biologic Ltd. Pharmaceuticals: MajorHealth Technology Part of NurExone Biologic, Inc., NurExone Biologic Ltd. is an Israeli company that offers a new approach to Spinal Cord Injury treatment. The private company is based in Bnei-Brak, Israel. The company believes that intranasal exosome administration offers an alternative to cell transplantation. The company was founded in 2020 by Yoram Nathan Drucker. Lior Shaltiel has been the CEO of the company since 2021. NurExone Biologic was acquired by EnerSpar Corp. on June 15, 2022.	Health Technology